secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001854270-24-000036
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Senti Bio CFO Deborah Knobelman resigns; search for interim CFO underway
------------------------------------------------------------------------

- Deborah Knobelman, Ph.D., CFO, Treasurer and Head of Corp. Dev., resigned effective May 3, 2024.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Company entered consulting agreement with Knobelman effective May 4, 2024, for transition; max payment $60,000.
- Company has initiated search to identify an interim CFO and treasurer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000036/0001854270-24-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000036/snti-20240423.htm
  HTML page:      https://secwatch.observer/filing/0001854270-24-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer